Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter March 10, 2017

Effect of aqueous extract of Aegle marmelos fruit and leaf on glycemic, insulinemic and lipidemic status of type 2 diabetic model rats

  • Sonchita R. Mudi EMAIL logo , Masfida Akhter , Subrata K. Biswas , Mohammad A. Muttalib , Subhagata Choudhury , Begum Rokeya and Liaquat Ali EMAIL logo



Aegle marmelos is a popular fruit plant in the Indian subcontinent, various parts of which are traditionally used against various illnesses including diabetes mellitus (DM). However, the underlying mechanisms of the antidiabetic effects of the plant are not clear, especially in type 2 DM. The present study was undertaken to investigate the effect of aqueous extracts of A. marmelos fruits (AMFE) and leaves (AMLE) on glycemic, lipidemic, insulinemic, insulin resistance and β-cell functional status of type 2 diabetic model rats.


An interventional study was designed using 20 type 2 diabetic rats. Type 2 DM was induced in Long Evans rats by a single intra-peritoneal injection of streptozotocin (90 mg/kg body weight) to 48 h old pups. Three months after induction of diabetes, the rats were divided into three independent groups: water-treated control group (n=6), AMLE-treated group (n=7) and AMFE-treated group (n=7). The rats were fed with extracts or water for 21 consecutive days and blood samples were collected at days 0 and 21 after an overnight fast. Data were expressed as mean±SD and analyzed by paired t-test or ANOVA as appropriate.


There were significantly lower blood glucose values in AMLE and AMFE groups at Endpoint compared to Baseline (mmol/l, mean±SD, Baseline vs. Endpoint, 7.04±1.0 vs. 6.06±0.92; p=0.032 and 7.04±0.97 vs. 5.87±0.93; p=0.047). There were also significantly lower serum insulin levels in AMLE and AMFE groups at Endpoint compared to Baseline (µIU/mL, mean±SD, Baseline vs. Endpoint, 14.02±5.48 vs. 7.57±2.90; p=0.026 and 11.54±4.83 vs. 6.58±4.36; p=0.008). Insulin resistance (HOMA-IR) was significantly improved both in AMLE and AMFE groups at Endpoint compared to Baseline (mean±SD, Baseline vs. Endpoint, 4.22±1.68 vs. 2.05±0.90; p=0.021 and 3.69±1.79 vs. 1.69±1.61; p=0.013). However, β-cell function or lipid profile did not show any significant alteration at Endpoint compared to Baseline in AMLE and AMFE groups.


Aqueous extracts of A. marmelos leaf and fruit have hypoglycemic property which seem to be mediated by lowering of insulin resistance. These findings highlight the therapeutic potential of the extracts of A. marmelos in human type 2 DM and provides strong impetus for further studies.


The authors wish to acknowledge the contribution of Dr. Shahinul Haque Khan, Associate Professor, Bangladesh University of Health Sciences, Dhaka, for his support in isolating aqueous extracts of Aegle marmelos fruits and leaves. The authors also acknowledge the contribution of Md. Billal Hossain and Md. Rafiqul Islam, Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders, Dhaka, for their help in animal experimentation.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission. SRM isolated extracts performed biochemical and animal experiments. MA and BR supervised the study and helped conduct the experiments. SKB and SRM analyzed and interpreted data and wrote the manuscript. MAM and SC supervised the study and critically reviewed the manuscript. LA conceived, designed, supervised the study and critically reviewed the manuscript.

  2. Research funding: This work was partly supported by a grant from the Bangladesh Medical Research Council.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–2128.10.1016/S0140-6736(12)61728-0Search in Google Scholar

2. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197–2223.10.1016/S0140-6736(12)61689-4Search in Google Scholar

3. International Diabetes Federation (IDF) [Internet]. Country estimates table 2011. IDF diabetes atlas. 6th ed, 2012. Accessed 7 Jun 2013 Available at in Google Scholar

4. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;36:S67–S74.10.2337/dc13-S067Search in Google Scholar PubMed PubMed Central

5. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2012;35:S11–S63.10.2337/dc12-s011Search in Google Scholar PubMed PubMed Central

6. DeFronzo R. From the triumvirate to the ominous octet: a new paradigm for the treatment of type diabetes mellitus. Diabetes. 2009;58:773–795.10.2337/db09-9028Search in Google Scholar PubMed PubMed Central

7. Goldberg RB, Holman R, Drucker DJ. Management of type 2 diabetes. N Engl J Med. 2008;358:293–297.10.1056/NEJMclde0708469Search in Google Scholar PubMed

8. Maity P, Hansda D, Bandyopadhyay U, Mishra DK. Biological activities of crude and chemical constituents of Bael, Aegle marmelos (L.) Corr. Indian J Exp Biol. 2009;47:849–861.Search in Google Scholar

9. Kumar V, Ahmed D, Anwar F, Ali M, Mujeeb M. Enhanced glycemic control, pancreas protective, antioxidant and hepatoprotective effects by umbelliferon-α-D-glucopyranosyl-(2(I) → 1(II))-α-D-glucopyranoside in streptozotocin induced diabetic rats. Springerplus. 2013;2:639.10.1186/2193-1801-2-639Search in Google Scholar PubMed PubMed Central

10. Gandhi GR, Ignacimuthu S, Paulraj MG. Hypoglycemic and β-cells regenerative effects of Aegle marmelos (L.) Corr. bark extract in streptozotocin-induced diabetic rats. Food Chem Toxicol. 2012;50:1667–1674.10.1016/j.fct.2012.01.030Search in Google Scholar PubMed

11. Narendhirakannan R, Subramanian S. Biochemical evaluation of the protective effect of Aegle marmelos (L.), Corr. leaf extract on tissue antioxidant defense system and histological changes of pancreatic beta-cells in streptozotocin-induced diabetic rats. Drug Chem Toxicol. 2010;33:120–130.10.3109/01480540903203984Search in Google Scholar PubMed

12. Narendhirakannan RT, Subramanian S, Kandawamy M. Biochemical evaluation of antidiabetogenic properties of some commonly used Indian plants on streptozotocin-induced diabetes in experimental rats. Clin Exp Pharmacol Physiol. 2006;33:1150–1157.10.1111/j.1440-1681.2006.04507.xSearch in Google Scholar PubMed

13. Ramesh B, Pugalendi KV. Influence of umbelliferone on membrane-bound ATPases in streptozotocin-induced diabetic rats. Pharmacol Rep. 2007;59:339–348.Search in Google Scholar

14. Kamalakkanan N, Prince PS. Antihyperlipidemic effect of water extract of Aegle marmelos fruit extract in streptozotocin induced diabetes rats. J Sci Food Agric. 2005;85:569–574.10.1002/jsfa.1978Search in Google Scholar

15. Upadhya S, Shanbhag KK, Suneetha G, Balachandra Naidu M. A study of hypoglycemic and antioxidant activity of Aegle marmelos in alloxan induced diabetic rats. Indian J Physiol Pharmacol. 2004;48:476–480.Search in Google Scholar

16. Sabu MC, Kuttan R. Antidiabetic activity of Aegle marmelos and its relationship with its antioxidant properties. Indian J Physiol Pharmacol. 2004;48:81–88.Search in Google Scholar

17. Ponnachan PT, Paulose CS, Panikkar KR. Effect of leaf extract of Aegle marmelose in diabetic rats. Indian J Exp Biol. 1993;4:345–347.Search in Google Scholar

18. Saravanan M, Pandikumar P, Saravanan S, Toppo E, Pazhanivel N, Ignacimuthu S. Lipolytic and antiadipogenic effects of (3, 3-dimethylallyl) halfordinol on 3T3-L1 adipocytes and high fat and fructose diet induced obese C57/BL6J mice. Eur J Pharmacol. 2014;740:714–721.10.1016/j.ejphar.2014.06.004Search in Google Scholar

19. Sharma AK, Bharti S, Goyal S, Arora S, Nepal S, Kishore K, et al. Upregulation of PPARγ by Aegle marmelos ameliorates insulin resistance and β-cell dysfunction in high fat diet fed-streptozotocin induced type 2 diabetic rats. Phytother Res. 2011;10:1457–1465.10.1002/ptr.3442Search in Google Scholar

20. Devi K, Silvaraj A, Vinoth PK, Syed ZA, Sathiaraj K, Senthil BK, et al. Hypolipidemic effect of Aegle marmelos leaf extract in streptozotocin (STZ) induced diabetic male albino rats. Int J Pharmtech Res. 2010;1:259–265.Search in Google Scholar

21. Bonner-Weir S, Trent DF, Honey RN, Weir GC. Responses of neonatal rat islets to streptozotocin: limited B-cell regeneration and hyperglycemia. Diabetes. 1981;30:64–69.10.2337/diab.30.1.64Search in Google Scholar

22. Ansari A, Shahriar MS, Hassan MM, Das SR, Rokeya B, Haque MA, et al. Emblica officinalis improves glycemic status and oxidative stress in STZ induced type 2 diabetic model rats. Asian Pac J Trop Med. 2014;7:21–25.10.1016/S1995-7645(13)60185-6Search in Google Scholar

23. Moniruzzaman M, Rokeya B, Ahmed S, Bhowmik A, Khalil MI, Gan SH. In vitro antioxidant effects of Aloe barbadensis Miller extracts and the potential role of these extracts as antidiabetic and antilipidemic agents on strepptozotocin-induced type 2 diabetic model rats. Molecules. 2012;17:12851–12867.10.3390/molecules171112851Search in Google Scholar PubMed PubMed Central

24. Ali L, Khan AK, Mamun MI, Mosihuzzaman M, Nahar N, Nur-e-Alam M, et al. Studies on hypoglycemic effects of fruit pulp seed and whole plant of Momordica charantia on normal and diabetic model rats. Planta Med. 1993;59:408–412.10.1055/s-2006-959720Search in Google Scholar PubMed

25. Sivaraj A, Devi K, Palani S, Vinoth PK, Sennthil BK, David E. Anti-hyperglycemic and anti-hyperlipidemic effect of combined plant extract of Cassia auriculata and Aegle marmelos in streptozotocin (STZ) induced diabetic albino rats. Int J Pharmtech Res. 2009;1:1010–1016.Search in Google Scholar

26. Friedewald WT, Levy RI, Fredrickson DS. Estimation of concentration of low- density lipoprotein cholesterol without the use of preparative ultracentrifuge. Clin Chem. 1972;18:449.10.1093/clinchem/18.6.499Search in Google Scholar

27. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Teacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β- cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985;28:412–419.10.1007/BF00280883Search in Google Scholar PubMed

28. Arulmozhi DK, Veerranjaneyulu A, Bodhankar SL. Neonatal streptozotocin-induced rat model of Type 2 diabetes mellitus. Indian J Pharmacol. 2004;4:217–221.Search in Google Scholar

29. Islam MS, Loots du T. Experimental rodent models of type 2 diabetes: a review. Methods Find Exp Clin Pharmacol. 2009;31:249–261.10.1358/mf.2009.31.4.1362513Search in Google Scholar PubMed

30. Adisakwattana S, Ruengsamran T, Kampa P, Sompong W. In vitro inhibitory effects of plant-based foods and their combinations on intestinal α-glucosidase and pancreatic α-amylase. BMC Complement Altern Med. 2012;12:110.10.1186/1472-6882-12-110Search in Google Scholar PubMed PubMed Central

31. Saha S, Verma R. Inhibitory potential of traditional herbs on α-amylase activity. Pharm Biol. 2012;50:326–331.10.3109/13880209.2011.608075Search in Google Scholar PubMed

32. Gautam S, Ishrat N, Singh R, Narender T, Srivastava AK. Aegeline from Aegle marmelos stimulates glucose transport via Akt and Rac1 signaling, and contributes to a cytoskeletal rearrangement through PI3K/Rac1. Eur J Pharmacol. 2015;762:419–429.10.1016/j.ejphar.2015.05.021Search in Google Scholar PubMed

Received: 2016-10-2
Accepted: 2017-1-9
Published Online: 2017-3-10
Published in Print: 2017-3-9

© 2017 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 29.9.2023 from
Scroll to top button